Peripartum cardiomyopathy: Review of the literature

Yonsei Medical Journal

Volumn 48, Issue 5, 2007, Pages 731-747

  Bhakta, Pradipta ^a   Biswas, Binay K ^b   Banerjee, Basuded ^c  

^a SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

^b BARNES JEWISH HOSPITAL   (United States)

^c B P KOIRALA INSTITUTE OF HEALTH SCIENCES   (Nepal)

Author keywords

Anesthesia; Cardiomyopathy; Complications; Obstetrics; Peripartum

Indexed keywords

ACETAZOLAMIDE; ADENOSINE; AMIODARONE; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCERYL TRINITRATE; HEPARIN; HYDRALAZINE; IMMUNOGLOBULIN; LEVOSIMENDAN; LOOP DIURETIC AGENT; NITRATE; NITROPRUSSIDE SODIUM; PROCAINAMIDE; QUINIDINE; SELENIUM; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG; VASODILATOR AGENT; WARFARIN;

AUTOIMMUNITY; CARDIOMYOPATHY; CESAREAN SECTION; CLINICAL FEATURE; DEHYDRATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOPPLER ECHOCARDIOGRAPHY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EXCRETION; DRUG MEGADOSE; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FETUS DISTRESS; GENERAL ANESTHESIA; GROWTH RETARDATION; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART FAILURE; HEART MASSAGE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HUMAN; HYPOTHYROIDISM; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFLAMMATORY DISEASE; INTENSIVE CARE; LOW DRUG DOSE; MEDICAL CARE; METABOLIC ALKALOSIS; MORTALITY; MULTIPLE ORGAN FAILURE; MYOCARDITIS; PATHOGENESIS; PERINATAL DEATH; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PREGNANCY; PREGNANCY COMPLICATION; PREOPERATIVE CARE; PROGNOSIS; PUERPERIUM; REGIONAL ANESTHESIA; REVIEW; RISK FACTOR; SELENIUM DEFICIENCY; SIDE EFFECT; SYSTOLIC HEART FAILURE; TERATOGENICITY; THIRD TRIMESTER PREGNANCY; THROMBOEMBOLISM; TREATMENT INDICATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION;

ANESTHESIA, OBSTETRICAL; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MORTALITY; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROGNOSIS; RECURRENCE; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 36249031895     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2007.48.5.731     Document Type: Review

References (99)

1. Demakis JG, Rahimtoola SH. Peripartum cardiomyopathy. Circulation 1971;44:964-8.
2. Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, et al. Natural course of peripartum cardiomyopathy. Circulation 1971;44:1053-61.
3. Veille JC, Peripartum cardiomyopathies: a review. Am J Obstet Gynecol 1984;148:805-18.
4. Hull E, Hafkesbring E. "Toxic" post partal heart disease. N Orleans Med Surg J 1937;89:550-7.
5. Brown CS, Bertolet BD. Peripartum cardiomyopathy: a comprehensive review. Am J Obstet Gynecol 1998;178: 409-14.
6. Cunningham FG, Pritchard JA, Hankins GD, Anderson PL, Lucas MJ, Armstrong KF. Peripartum heart failure: idiopathic cardiomyopathy or compounding cardiovascular events? Obstet Gynecol 1986;67:157-68.
7. Pierce JA, Price BO, Joyce JW. Familial occurrence of postpartal heart failure. Arch Intern Med 1963;111: 651-5.
8. van Hoeven KH, Kitsis RN, Katz SD, Factor SM. Peripartum versus idiopathic dilated cardiomyopathy in young women-a comparison of clinical, pathologic and prognostic features. Int J Cardiol 1993;40-57-65.
9. Lampert MB, Lang RM. Peripartum cardiomyopathy. Am Heart J 1995;130:860-70.
10. Rizeq MN, Rickenbacher PR, Fowler MB, Billingham ME. Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol 1994;74:474-7.
11. Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, et al. Peripartum. cardiomyopathy: National Heart, Lung and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendation and review. JAMA 2000;283:1183-8.
12. Hibbard JU, Lindheimer M, Lang RM. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol 1999;94: 311-6.
13. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342: 1077-84.
14. Homans DC. Peripartum cardiomyopathy. N Engl J Med 1985;312:1432-7.
15. Ritchie C. Clinical contribution to the pathology, diagnosis, and treatment of certain chronic diseases of the heart: Edinb Med Surg J 1849;2:333-42.
16. Gouley BA, McMillan TM, Bellet S. Idiopathic myocardial degeneration associated with pregnancy especially the puerperium. Am J Med Sci 1937;19:185-99.
17. Witlin AG, Mabie WC, Sibai BM. Peripartum-cardiomyopathy: an ominous diagnosis. Am J Obstet Gynecol 1997;176:182-8.
18. Desai D, Moodley, J, Naidoo D. Peripartum cardiomyopathy: experiences at King Edward VIII Hospital, Durban, South Africa and a review of the literature. Trop Doct 1995;25:118-23.
19. Fett JD, Christie LG, Carraway RD, Murphy JG. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 2005;80:1602-6.
20. Sanderson JE, Adesanya CO, Anjorin FI, Parry EH. Postpartum cardiac failure-heart failure due to volume overload? Am Heart J 1979;97:613-21.
21. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006;368:687-93.
22. Heider AL, Kuller JA, Strauss RA, Wells SR. Peripartum cardiomyopathy: a review of the literature. Obstet Gynecol Surv 1999;54:526-31.
23. Ro A, Frishman WH. Peripartum cardiomyopathy. Cardiol Rev 2006;14:35-42.
24. Burch GE, McDonald CD, Walsh JJ. The effect of prolonged bed rest on postpartal cardiomyopathy. Am Heart J 1971;81:186-201.
25. Midei MG, DeMent SH, Feldman AM, Hutchins GM, Baughaman KL. Peripartum myocarditis and cardiomyopathy. Circulation 1990;81:922-8.
26. Lee W. Clinical management of gravid women with peripartum cardiomyopathy. Obstet Gynecol Clin North Am 1991;18:257-71.
27. Ford RF, Barton JR, O'brien JM, Hollingsworth PW. Demographics, management and outcome of peripartum cardiomyopathy in a community hospital. Am J Obstet Gynecol 2000;182:1036-8.
28. Whitehead SJ, Berg CJ, Chang J. Pregnancy-related mortality due to cardiomyopathy: United States, 1991-1997. Obstet Gynecol 2003;102:1326-31.
29. Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005;111:2050-5.
30. Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sarelil P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/Apo-1. J Am Coll Cardiol 2000; 35:701-5.
31. Sliwa K, Förster O, Libhaber E, Fett JD, Sundstrom JB, Hilfiker-Kleiner D, et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J 2006;27: 441-6.
32. Velickovic IA, Leicht CH. Peripartum cardiomyopathy and cesarean section: report of two cases and literature review. Arch Gynecol Obstet 2004;270:307-10.
33. Diao M, Diop IB, Kane A, Camara S, Kane A, Sarr M, et al. Electrocardiographic recording of long duration (Holter) of 24 hours during idiopathic cardiomyopathy of the peripartum. Arch Mal Coeur Vaiss 2004;97:25-30.
34. Fett JD, Carraway RD, Dowell DL, King ME, Pierre R. Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti. Am J Obstet Gynecol 2002; 186:1005-10.
35. Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J 2006;152:509-13.
36. Zangrillo A, Landoni G, Pappalardo F, Oppizzi M, Torri G. Different anesthesiological management in two high risk pregnant women with heart failure undergoing emergency cesarean section. Minerva Anestesiol 2005; 71:227-36.
37. Kaufman I, Bondy R, Benjamin A. Peripartum cardiomyopathy and thromboembolism; anesthetic management and clinical course of an obese, diabetic patient. Can J Anaesth 2003;50:161-5.
38. Ravikishore AG, Kaul UA, Sethi KK, Khalilullah M. Peripartum cardiomyopathy: prognostic variables at initial evaluation. Int J Cardiol 1991;32:377-80.
39. Yahagi N, Kumon K, Nakatani T, Ishikawa T, Tanigami H, Eishi K, et al. Peripartum cardiomyopathy and tachycardia followed by multiple organ failure. Anesth Analg 1994;79:581-2.
40. Benlolo S, Lefoll C, Katchatouryan V, Payen D, Mebazaa A. Successful use of levosimendan in a patient with peripartum cardiomyopathy. Anesth Analg 2004; 98:822-4.
41. Malinow AM, Butterworth JF, Johnson MD, Safon L, Rein M, Hartwell B, et al. Peripartum cardiomyopathy presenting at cesarean delivery. Anesthesiology 1985; 63:545-7.
42. Shnaider R, Ezri T, Szmuk P, Larson S, Warters RD, Katz H. Combined spinal-epidural anesthesia for cesarean section in a patient with peripartum dilated cardiomyopathy. Can J Anaesth 2001;48:681-3.
43. Avila WS, de Carvalho MEC, Tschaen CK, Rossi EG, Grinberg M, Mady C, et al. Pregnancy and peripartum cardiomyopathy. A comparative and prospective study. Arq Bras Cardiol 2002;79:484-93.
44. Elkayam U, Tummala PP, Rao K, Akhter MW, Karaalp IS, Wani OR, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001;344:1567-71.
45. O'Connell JB, Costanzo-Nordin MR, Subramanlan R, Robinson JA, Wallis DE, Scanlon PJ, et al. Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics. J Am Coll Cardiol 1986;8:52-6.
46. Melvin KR, Richardson PJ, Olsen EG, Daly K, Jackson G. Peripartum cardiomyopathy due to myocarditis. N Engl J Med 1982;307:731-4.
47. Sutton MS, Cole P, Plappert M, Saltzman D, Goldhaber S. Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. Am Heart J 1991;121:1776-8.
48. Cénac A, Gaultier Y, Devillechabrolle A, Moulias R. Enterovirus infection in peripartum cardiomyopathy. Lancet 1988;2:968-9.
49. Cénac A, Simonoff M, Moretto P, Djibo A. A low plasma selenium is a risk factor for peripartum cardiomyopathy. A comparative study in Sahelian Africa. Int J Cardiol 1992;36:57-9.
50. Ansari AA, Fett JD, Carraway RE, Mayne AE, Onlamoon N, Sundstrom JB. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol 2002;23:301-24.
51. Podewski EK, Hilfiker A, Kaminski K, Quint A, Apuya D, Podewski E, et al. Stat3 protects female hearts from postpartum cardiomyopathy in the mouse: the potential role of prolactin (Abstract P2178). Munich: European Society of Cardiology Meeting; 2004.
52. Hayakawa Y, Chandra M, Mial W, Shirani J, Brown JH, Dorn GW, et al. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice. Circulation 2003;108:3036-41.
53. Fett JD, Ansari AA, Sundstrom JB, Combs GF. Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. Int J Cardiol 2002;86:311-6.
54. Felker GM, Jaeger CJ, Klodas E, Thiemann DR, Hare JM, Hruban RH, et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J 2000;140:785-91.
55. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology molecular pathology. Circulation 2004;109:1250-8.
56. Borczuk AC, van Hoeven KH, Factor SM. Review and hypothesis: the eosinophil and peripartum heart disease (myocarditis and coronary artery dissection)-coincidence or pathogenetic significance? Cardiovasc Res 1997;33:527-32.
57. Bradham WS, Bozkurt B, Gunasinghe H, Mann D, Spinale FG. Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. Cardiovasc Res 2002;53:822-30.
58. Bültmann BD, Klingel K, Näbauer M, Wallwiener D, Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 2005;193:363-5.
59. Zimmermann O, Kochs M, Zwaka TP, Kaya Z, Lepper PM, Bienek-Ziolkowski M, et al. Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy. Int J Cardiol 2005;104:92-100.
60. Sakakibara S, Sekiguchi M, Konno S, Kusumoto M. Idiopathic postpartum cardiomyopathy: report of a case with special reference to its ultrastructural changes in the myocardium as studies by endomyocardial biopsy. Am Heart J 1970;80:385-95.
61. Nelson JL. Pregnancy, persistent microchimerism and autoimmune disease. J Am Med Womens Assoc 1998; 53:31-2,47.
62. McMullan MR, Moore CK, O'Connell JB. Diagnosis and management of peripartum cardiomyopathy. Hosp Pract (Off Ed) 1993;28:89-92,96-8,103-4.
63. Warraich RS, Sliwa K, Damasceno A, Carraway R, Sundrom C, Arif G, et al. Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy. Am Heart J 2005;150:263-9.
64. Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003;24:761-81.
65. Phillips SD, Warnes CA. Peripartum cardiomyopathy: current therapeutic perspectives. Curr Treat Options Cardiovasc Med 2004;6:481-8.
66. Levander OA, Beck MA. Selenium and viral virulence. Br Med Bull 1999;55:528-33.
67. Saito Y, Hashimoto T, Sasaki M, Hanaoka S, Sugai K. Effect of selenium deficiency on cardiac function of individuals with severe disabilities under long-term tube feeding. Dev Med Child Neurol 1998;40:743-8.
68. Lampert MB, Hibbard J, Weinert L, Briller J, Lindheimer M, Lang RM. Peripartum heart failure associated with prolonged tocolytic therapy. Am J Obstet Gynecol 1993;168:493-5.
69. Ray P, Murphy GJ, Shutt LE. Recognition and management of maternal cardiac disease in pregnancy. Br J Anaesth 2004;93:428-39.
70. Coulson CC, Thorp JM, Mayer DC, Cefalo RC. Central hemodynamic effects of recombinant human relaxin in the isolated, perfused rat heart model. Obstet Gynecol 1996;87:610-2.
71. Cénac A, Djibo A, Chaigneau C, Velmans N, Orfila J. Are anti-Chlamydia pneumoniae antibodies prognosis indicators for peripartum cardiomyopathy? J Cardiovasc Risk 2003;10:195-9.
72. Sundstrom JB, Fett JD, Carraway RD, Ansari AA. Is peripartum cardiomyopathy an organ specific autoimmune disease? Autoimmun Rev 2002;1:73-7.
73. Dickfeld T, Gagliardi JP, Marcos J, Russell SD. Peripartum cardiomyopathy presenting as an acute myocardial infarction. Mayo Clin Proc 2002;77:500-1.
74. Box LC, Hanak V, Arciniegas JG. Dual coronary emboli in peripartum cardiomyopathy. Tex Heart Inst J 2004; 31:442-4.
75. McIndoe AK, Hammond EJ, Babington PC. Peripartum cardiomyopathy presenting as a cardiac arrest at induction of anaesthesia for emergency caesarean section. Br J Anaesth 1995;75:97-101.
76. Lampert MB, Weinert L, Hibbard J, Korcarz C, Lindheimer M, Lang RM. Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynecol 1997;176:189-95.
77. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333:269-75.
78. Aziz TM, Burgess MI, Acladious NN, Campbell CS, Rahman AN, Yonan N, et al. Heart transplantation for peripartum cardiomyopathy: a report of three cases and a literature review. Cardiovasc Surg 1999;7:565-7.
79. Okutomi T, Saito M, Amano K, Fukuoka K, Hoka S. Labour analgesia guided by echocardiography in a parturient with primary dilated cardiomyopathy. Can J Anaesth 2005;52:622-5.
80. Barfield WE. Wolff-Parkinson-White syndrome and peripartum cardiomyopathy in a pregnant patient. Am J Obstet Gynecol 1982;144:989-90.
81. Ardehali H, Kasper EK, Baughman KL. Peripartum cardiomyopathy. Minerva Cardioangiol 2003;51:41-8.
82. Page, RL. Treatment of arrhythmias during pregnancy. Am Heart J 1995;130:871-6.
83. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-17.
84. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325: 303-10.
85. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodepine Survival Evaluation Study Group. N Engl J Med 1996;335:1107-14.
86. Mohler ER, Sorensen LC, Ghali JK, Schocken DD, Willis PW, Bowers JA, et al. Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial. Prospective Randomized Amlodipine Survival Evaluation. J Am Coll Cardiol 1997;30:35-41.
87. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996;334:1349-55.
88. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:627S-44S.
89. Bozkurt B, Villaneuva FS, Holubkov R, Tokarczyk T, Alvarez RJ, MacGowan GA, et al. Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol 1999;34:177-80.
90. McNamara DM, Holubkov R, Starling RC, Dec GW, Loh E, Torre-Amione G, et al. Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation 2001;103:2254-9.
91. Veille JC, Zaccaro D. Peripartum cardiomyopathy: summary of an international survey on peripartum cardiomyopathy. Am J Obstet Gynecol 1999;181:315-9.
92. Aravot DJ, Banner NR, Dhalla N, Fitzgerald M, Khaghani A, Radley-Smith R, et al. Heart transplantation for peripartum cardiomyopathy. Lancet 1987;2:1024.
93. Lewis R, Mabie WC, Burlew B, Sibai BM. Biventricular assist device as a bridge to cardiac transplantation in the treatment of peripartum cardiomyopathy. South Med J 1997;90:955-8.
94. George LM, Gatt SP, Lowe S. Peripartum cardiomyopathy: four case histories and a commentary on anaesthetic management. Anaesth Intensive Care 1997; 25:292-6.
95. Gambling DR, Flanagan ML, Huckell VF, Lucas SB, Kim JH. Anaesthetic management and non-invasive monitoring for cesarean section in a patient with cardiomyopathy. Can J Anaesth 1987;34:505-8.
96. McCarroll CP, Paxton LD, Elliott P, Wilson DB. Use of remifentanil in a patient with peripartum cardiomyopathy requiring Caesarean section. Br J Anaesth 2001;86:135-8.
97. Colucci WS, Elkayam U, Horton DP, Abraham WT, Bourge RC, Johnson AD, et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 2000;343:246-53.
98. Mellor DJ, Bodenham A. Infiltration anaesthesia in the management of Caesarean section in a patient with peripartum cardiomyopathy. Anaesthesia 1996;51:409.
99. Ceci O, Berardesca C, Caradonna F, Corsano P, Guglielmi R, Nappi, L. Recurrent peripartum cardiomyopathy. Eur J Obstet Gynecol Reprod Biol 1998;76: 29-30.